相关实验视频

Updated: Jul 15, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

通过AAV9-Tnnt2-SaCas9-miR122TS载体进行心脏特异性基因编辑

Luzi Yang¹, Congting Guo¹, Yueshen Sun²

¹School of Basic Medical Sciences, Institute of Cardiovascular Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University Health Science Center, Beijing, China.

|March 14, 2025

概括

这项研究引入了一种新的腺相关病毒 (AAV9) 载体,可以增强心脏特异性基因编辑. 通过结合microRNA-122目标序列,它有效地减少了肝脏中不必要的基因表达.

科学领域:

分子生物学分子生物学
基因治疗基因治疗
心血管研究研究心血管研究

背景情况:

腺相关病毒血清型9 (AAV9) 具有心脏素T (Tnnt2) 促进体通常是心脏特异性的.
肝脏内外AAV9-Tnnt2表达在CRISPR/Cas9基因编辑中可能具有重要意义,影响结果.
微RNA-122 (miR122) 对肝脏组织具有高度特异性.

研究的目的:

开发一种新的AAV9载体,用于增强心脏特异性基因编辑.
通过减少子宫外表达来减轻肝脏中的非目标基因编辑.
为构建和验证这种改进的矢量提供详细的协议.

主要方法:

用于AAV9-Tnnt2-SaCas9-miR122TS载体的sgRNA的设计和质粒的构造.
在小鼠模型中进行AAV包装和体内验证.
利用公开可用的材料和工具进行矢量开发和分析.

主要成果:

成功构建和验证了AAV9-Tnnt2-SaCas9-miR122TS向量.
由于miR122标序列,在肝脏中证明了异胎基因表达的减少.
精确量化心脏特异性基因编辑效率使用安普利康测序.

结论:

开发的AV9载体与miR122目标序列实现了强大的心脏特异性基因编辑.
这种方法有效地规避了基于肝脏的基因表达泄漏,提高了特异性.
该协议有助于精确和敏感地评估基因编辑效率和组织热带性 in vivo.

关键词:

腺相关病毒的病毒.心脏特异性的心脏特异性基因编辑基因编辑微型RNA-122的目标序列.

更多相关视频

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

相关概念视频

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.